514 results on '"Rutkowski, Boleslaw"'
Search Results
2. Amino acid profile after oral nutritional supplementation in hemodialysis patients with protein-energy wasting
3. Water soluble vitamins and peritoneal dialysis – State of the art
4. Hepatocyte nuclear factors as possible C-reactive protein transcriptional inducer in the liver and white adipose tissue of rats with experimental chronic renal failure
5. Hepatocyte Nuclear Factor-1α Increases Fibrinogen Gene Expression in Liver and Plasma Fibrinogen Concentration in Rats with Experimental Chronic Renal Failure
6. The influence of renin angiotensin aldosterone system blockers on asymmetric dimethylarginine levels in patients with chronic glomerulonephritis
7. Disorders of the anterior attentional-intentional system in patients with end stage renal disease: Evidence from reaction time studies
8. Slowing with end-stage renal disease: Attentive but unprepared to act
9. Low-Sodium Versus Standard-Sodium Peritoneal Dialysis Solution in Hypertensive Patients: A Randomized Controlled Trial
10. Up-regulation of Hnf1α gene expression in the liver of rats with experimentally induced chronic renal failure – A possible link between circulating PCSK9 and triacylglycerol concentrations
11. Nephroprotective Action of Renin-Angiotensin-Aldosterone System Blockade in Chronic Kidney Disease Patients: The Landscape After ALTITUDE and VA NEPHRON-D Trails
12. Hepatocyte Nuclear Factor 1α Proinflammatory Effect Linked to the Overexpression of Liver Nuclear Factor–κB in Experimental Model of Chronic Kidney Disease
13. Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over study
14. Up-regulation of liver Pcsk9 gene expression as a possible cause of hypercholesterolemia in experimental chronic renal failure
15. Vitamin B6 and the Immunity in Kidney Transplant Recipients
16. Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failure
17. Safety of intravenous ferric carboxymaltose versus oral iron in patients with nondialysis-dependent CKD: an analysis of the 1-year FIND-CKD trial
18. Cellular Toxicity of Nicotinamide Metabolites
19. Availability of Renal Replacement Therapy in Central and Eastern Europe
20. Explosion of Renal Replacement Therapy after the Implosion of the Soviet Empire
21. Accelerated Purine Base Salvage — A Possible Cause of Elevated Nucleotide Pool in the Erythrocytes of Patients with Uraemia
22. Renal anaemia treatment in haemodialysis patients in the Central and Eastern European countries in everyday clinical practice follow-up
23. Distribution of Purine Nucleotides in Uremic Fluids and Tissues
24. Adenine Nucleotide Catabolism in the Erythrocytes of Uraemic Patients
25. Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study
26. Refeeding after prolonged food restriction differentially affects hypothalamic and adipose tissue leptin gene expression
27. Renal replacement therapy in Europe-a summary of the 2010 ERA-EDTA Registry Annual Report
28. Survival with low- and high-flux dialysis
29. Feedback Inhibition of Cholesterol Biosynthesis by Dietary Cholesterol in Experimental Chronic Renal Failure
30. Effectiveness of Antihypertensive Treatment in Patients With Chronic Kidney Disease
31. Nicotinamide Metabolites Accumulate in the Tissues of Uremic Rats
32. Elder Patients - What is the Best Vascular Hemodialysis Access?
33. Triple Pharmacological Blockade of the Renin-Angiotensin-Aldosterone System in Nondiabetic CKD: An Open-Label Crossover Randomized Controlled Trial
34. CKD MBD
35. Accumulation of poly(ADP-ribose) polymerase inhibitors in children with chronic renal failure
36. Carnitine Content in Different Muscles of Patients Receiving Maintenance Hemodialysis
37. The Potential Role of Sterol Regulatory Element Binding Protein Transcription Factors in Renal Injury
38. Increased gene expression of liver SREBP-2 in experimental chronic renal failure
39. The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma
40. Nicotinamide Metabolites
41. Dialysis in Eastern Europe
42. Contribution of increased HMG-CoA reductase gene expression to hypercholesterolemia in experimental chronic renal failure
43. COSMOS: the dialysis scenario of CKD–MBD in Europe
44. Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure
45. Diurnal rhythm of cholesterol biosynthesis in experimental chronic renal failure
46. Interrelationship Between Uremic Toxicity and Oxidative Stress
47. Bioelectrical Impedance Analysis Before Versus After a Hemodialysis Session in Evaluation of Nutritional Status
48. Accelerated degradation of adenine nucleotide in erythrocytes of patients with chronic renal failure
49. Low cholesterol in dialysis patients––causal factor for mortality or an effect of confounding?
50. VITAMIN B6 AND IMMUNITY IN ELDERLY KIDNEY TRANSPLANT RECIPIENTS: RO-278
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.